These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 7620222)

  • 21. 9-[3-(2-Nitro-1-imidazolyl)propylamino]-1,2,3,4-tetrahydroacridine hydrochloride. A novel DNA-affinic hypoxic cell cytotoxin and radiosensitizer. Comparison with NLA-1.
    Papadopoulou MV; Rosenzweig HS; Doddi M; Bloomer WD
    Oncol Res; 1994; 6(9):439-48. PubMed ID: 7703530
    [TBL] [Abstract][Full Text] [Related]  

  • 22. N-[2-(2-methyl-5-nitroimidazolyl)ethyl]-4-(2-nitroimidazolyl)butanamide (NSC 639862), a bisnitroimidazole with enhanced selectivity as a bioreductive drug.
    Moselen JW; Hay MP; Denny WA; Wilson WR
    Cancer Res; 1995 Feb; 55(3):574-80. PubMed ID: 7834627
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Naphthalimide intercalators with chiral amino side chains: effects of chirality on DNA binding, photodamage and antitumor cytotoxicity.
    Yang Q; Yang P; Qian X; Tong L
    Bioorg Med Chem Lett; 2008 Dec; 18(23):6210-3. PubMed ID: 18930399
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Isoquino[4,5-bc]acridines: design, synthesis and evaluation of DNA binding, anti-tumor and DNA photo-damaging ability.
    Yang P; Yang Q; Qian X; Tong L; Li X
    J Photochem Photobiol B; 2006 Sep; 84(3):221-6. PubMed ID: 16714120
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Structure-activity studies with cytotoxic anthrapyrazoles.
    Begleiter A; Lin D; Larson KK; Lang J; Wu X; Cabral T; Taylor H; Guziec LJ; Kerr PD; Hasinoff BB; Guziec FS
    Oncol Rep; 2006 Jun; 15(6):1575-80. PubMed ID: 16685398
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sequence selectivity of topoisomerase II DNA cleavage stimulated by mitoxantrone derivatives: relationships to drug DNA binding and cellular effects.
    De Isabella P; Capranico G; Palumbo M; Sissi C; Krapcho AP; Zunino F
    Mol Pharmacol; 1993 May; 43(5):715-21. PubMed ID: 8388987
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Structure-activity relationships of 1,2,4-benzotriazine 1,4-dioxides as hypoxia-selective analogues of tirapazamine.
    Hay MP; Gamage SA; Kovacs MS; Pruijn FB; Anderson RF; Patterson AV; Wilson WR; Brown JM; Denny WA
    J Med Chem; 2003 Jan; 46(1):169-82. PubMed ID: 12502371
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthesis and biological evaluation of mono- and bis-[(alkylamino)alkylamino] substituted thienopyridopyridazines, a new class of potential antitumor agents.
    Antonini I; Cola D; Polucci P; Palmieri GF; Martelli S; Jenkins TC
    Farmaco; 1996 Jan; 51(1):41-7. PubMed ID: 8721760
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characteristics of the interaction of anthrapyrazole anticancer agents with deoxyribonucleic acids: structural requirements for DNA binding, intercalation, and photosensitization.
    Hartley JA; Reszka K; Zuo ET; Wilson WD; Morgan AR; Lown JW
    Mol Pharmacol; 1988 Mar; 33(3):265-71. PubMed ID: 3352592
    [TBL] [Abstract][Full Text] [Related]  

  • 30. DNA recognition by intercalators and hybrid molecules.
    Waring MJ; Bailly C
    J Mol Recognit; 1994 Jun; 7(2):109-22. PubMed ID: 7826671
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interactions of antitumor triazoloacridinones with DNA.
    Koba M; Konopa J
    Acta Biochim Pol; 2007; 54(2):297-306. PubMed ID: 17446935
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mechanism of action of bisimidazoacridones, new drugs with potent, selective activity against colon cancer.
    Hernandez L; Cholody WM; Hudson EA; Resau JH; Pauly G; Michejda CJ
    Cancer Res; 1995 Jun; 55(11):2338-45. PubMed ID: 7757985
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synthesis and structure-activity correlations of the cytotoxic bifunctional 1,4-diamidoanthraquinone derivatives.
    Huang HS; Chiu HF; Lee AL; Guo CL; Yuan CL
    Bioorg Med Chem; 2004 Dec; 12(23):6163-70. PubMed ID: 15519160
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The interaction of intercalators and groove-binding agents with DNA triple-helical structures: the influence of ligand structure, DNA backbone modifications and sequence.
    Wilson WD; Mizan S; Tanious FA; Yao S; Zon G
    J Mol Recognit; 1994 Jun; 7(2):89-98. PubMed ID: 7826678
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Extravascular transport of the DNA intercalator and topoisomerase poison N-[2-(Dimethylamino)ethyl]acridine-4-carboxamide (DACA): diffusion and metabolism in multicellular layers of tumor cells.
    Hicks KO; Pruijn FB; Baguley BC; Wilson WR
    J Pharmacol Exp Ther; 2001 Jun; 297(3):1088-98. PubMed ID: 11356933
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Metabolism of bioreductive antitumor compounds by purified rat and human DT-diaphorases.
    Beall HD; Mulcahy RT; Siegel D; Traver RD; Gibson NW; Ross D
    Cancer Res; 1994 Jun; 54(12):3196-201. PubMed ID: 8205540
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Studies of structure-activity relationship of nitroxide free radicals and their precursors as modifiers against oxidative damage.
    Krishna MC; DeGraff W; Hankovszky OH; Sár CP; Kálai T; Jeko J; Russo A; Mitchell JB; Hideg K
    J Med Chem; 1998 Aug; 41(18):3477-92. PubMed ID: 9719601
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 9-[3-(2-Nitro-1-imidazolyl)propylamino]-cyclopenteno[b]quinoline hydrochloride (NLCPQ-1). A novel DNA-affinic bioreductive agent as chemosensitizer: mechanistic studies. II.
    Papadopoulou MV; Rosenzweig HS; Ji M; Khan SH; Bloomer WD
    Oncol Res; 1998; 10(3):163-73. PubMed ID: 9700727
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthesis and evaluation of 9-anilinothiazolo[5,4-b]quinoline derivatives as potential antitumorals.
    Rodríguez-Loaiza P; Quintero A; Rodríguez-Sotres R; Solano JD; Lira-Rocha A
    Eur J Med Chem; 2004 Jan; 39(1):5-10. PubMed ID: 14987829
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bis-benzimidazole anticancer agents: targeting human tumour helicases.
    Soderlind KJ; Gorodetsky B; Singh AK; Bachur NR; Miller GG; Lown JW
    Anticancer Drug Des; 1999 Feb; 14(1):19-36. PubMed ID: 10363025
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.